- Previous Close
3.430 - Open
3.300 - Bid 3.400 x --
- Ask 3.470 x --
- Day's Range
3.300 - 3.460 - 52 Week Range
2.860 - 5.200 - Volume
11,500 - Avg. Volume
107,627 - Market Cap (intraday)
2.857B - Beta (5Y Monthly) -0.66
- PE Ratio (TTM)
9.35 - EPS (TTM)
0.370 - Earnings Date --
- Forward Dividend & Yield 0.10 (2.56%)
- Ex-Dividend Date May 29, 2025
- 1y Target Est
5.47
OrbusNeich Medical Group Holdings Limited, an investment holding company, researches, develops, manufactures, trades in, sells, and markets medical devices/instruments used for the treatment of coronary and peripheral vascular diseases in Japan, Europe, the Middle East, Africa, the Asia Pacific, the People's Republic of China, and the United States. The company offers semi-compliant balloons and scoring balloons for pre-dilatation and lesion preparation, stents for implantation, non-compliant balloons for post-dilatation, and specialty catheters, as well as sirolimus-eluting coronary stents, peripheral self-expandable stents, and paclitaxel-coated PTCA and PTA balloons. Its product portfolio covers various treatment processes in percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures. The company was founded in 2001 and is headquartered in Sha Tin, Hong Kong. OrbusNeich Medical Group Holdings Limited is a subsidiary of Harmony Tree Limited.
orbusneich.com1,331
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: 6929.HK
View MorePerformance Overview: 6929.HK
Trailing total returns as of 4/9/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 6929.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 6929.HK
View MoreValuation Measures
Market Cap
2.83B
Enterprise Value
932.70M
Trailing P/E
9.17
Forward P/E
14.71
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.22
Price/Book (mrq)
0.93
Enterprise Value/Revenue
0.73
Enterprise Value/EBITDA
2.82
Financial Highlights
Profitability and Income Statement
Profit Margin
24.20%
Return on Assets (ttm)
5.17%
Return on Equity (ttm)
10.43%
Revenue (ttm)
164.1M
Net Income Avi to Common (ttm)
39.72M
Diluted EPS (ttm)
0.370
Balance Sheet and Cash Flow
Total Cash (mrq)
260.77M
Total Debt/Equity (mrq)
1.07%
Levered Free Cash Flow (ttm)
--